Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
about
Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1DHIV-1 epidemic in the Caribbean is dominated by subtype B.Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical managementLentiviral vectors can be used for full-length dystrophin gene therapyGenotypic prediction of tropism of highly diverse HIV-1 strains from CameroonCharacterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, BrazilMolecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India.Near full-length genomic characterization of a HIV type 1 BC recombinant strain from Manipur, India.Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms.First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar.The APPEESFRS Peptide, Restricted by the HLA-B*35:01 Molecule, and the APPEESFRF Variant Derived from an Autologous HIV-1 Strain Induces Polyfunctional Responses in CD8+ T Cells.Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia.Lentiviral vectors can be used for full-length dystrophin gene therapy.
P2860
Q28538687-C336D7A2-60F5-476E-8D33-514C0B30693DQ30375505-FAE258A1-6EAF-40D3-8510-9C68BCA830B3Q30376101-E233BFCF-4D07-442F-82A6-CDAF3B5433D4Q33668822-28B81A11-9D8E-4F04-A735-A14CE9B394B6Q34473354-29C7DB6C-C140-4673-9313-CB554D5DB9DFQ36177522-897B2188-471C-406D-B52C-DD25D824D5ADQ37111469-6E64F46D-9F6B-48A0-A51F-A3EE70DFE0E8Q39600404-88FBBCDE-E4D9-464A-A37D-902854E18995Q40183063-CA367A95-9619-4A2C-8FB3-CA3E42BE302DQ40442868-CEDAFCA4-DFCC-44F2-A799-59443EAD593BQ40602269-D8E1489E-5876-47EA-8550-541FFE2BA096Q41169502-B1643A31-4D30-4495-B072-155626074725Q42133771-305C093B-85E2-4A87-B3F4-56A9D94300A8Q53426367-F84BEFCE-A381-45DB-97D8-9A62126AA1E3
P2860
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@ast
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@en
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@nl
type
label
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@ast
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@en
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@nl
prefLabel
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@ast
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@en
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@nl
P2093
P2860
P1433
P1476
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma.
@en
P2093
Anne M Sill
Farley Cleghorn
Lindsay M Eyzaguirre
Niel T Constantine
William A Blattner
Yuka Nadai
P2860
P356
10.1371/JOURNAL.PONE.0001420
P407
P50
P577
2008-01-09T00:00:00Z